Amicus Therapeutics Inc. (FOLD) |
|
12.475 0.285 (2.34%)
|
05-29 16:00 |
|
Open: |
12.2 |
Pre. Close: |
12.19 |
|
High:
|
12.52 |
Low:
|
11.89 |
|
Volume:
|
1,709,207 |
Market Cap:
|
3,214M |
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
12.532 - 12.592 |
12.592 - 12.645 |
|
Low:
|
11.749 - 11.817 |
11.817 - 11.876 |
|
Close:
|
12.374 - 12.484 |
12.484 - 12.578 |
|
Technical analysis |
as of: 2020-05-29 4:26:13 PM |
|
Overall:
|
  |
| Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 15.37 One year: 17.95 |
| Support: |
Support1: 11.83 Support2: 11.01 |
| Resistance: |
Resistance1: 13.16 Resistance2: 15.37 |
| Pivot: |
12.15 |
| Moving Average: |
MA(5): 12.40  MA(20): 12.04
MA(100): 10.32 MA(250): 10.27 |
| MACD: |
MACD(12,26): 0.34 Signal(9): 0.38 |
| Stochastic oscillator: |
%K(14,3): 63.33 %D(3): 63.85 |
| RSI: |
RSI(14): 56.34 |
| 52-week: |
High: 13.39 Low: 6.25 Change(%): 10.8 |
| Average Vol(K): |
3-Month: 339397 10-Days: 300042 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.FOLD has closed below upper band by 31.5%. Bollinger Bands are 31.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Sat, 09 May 2020
Amicus Therapeutics Inc (FOLD) Q1 2020 Earnings Call Transcript - Motley Fool
Thu, 07 May 2020
Amicus Therapeutics (FOLD) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Sun, 10 May 2020
Analysts Are Updating Their Amicus Therapeutics, Inc. (NASDAQ:FOLD) Estimates After Its First-Quarter Results - Yahoo Finance
Thu, 28 May 2020
Amicus Therapeutics Inc. [FOLD] Revenue clocked in at $208.70 million, up 27.82% YTD: What’s Next? - The DBT News
Thu, 28 May 2020
Growth Myths About Amicus Therapeutics, Inc. (FOLD) You Probably Still Believe - The News Heater
Mon, 11 May 2020
Amicus Therapeutics Inc. (FOLD) Soars 3.43% on May 11 - Equities.com
|
Financial Analysis |
| Growth |
|
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
258 |
| Shares Float (M) |
205 |
|
% Held by Insiders
|
1.10 |
|
% Held by Institutions
|
109.87 |
|
Shares Short (K)
|
34,200 |
|
Shares Short P. Month (K)
|
35,450 |
Stock Financials |
|
EPS
|
-1.290 |
|
EPS Est This Year
|
-1.320 |
|
EPS Est Next Year
|
-1.020 |
|
Book Value (p.s.)
|
1.560 |
|
Profit Margin
|
-155.73 |
|
Operating Margin
|
-142.76 |
|
Return on Assets (ttm)
|
-24.8 |
|
Return on Equity (ttm)
|
-76.1 |
|
Qtrly Rev. Growth
|
77.8 |
|
Gross Profit (p.s.)
|
0.622 |
|
Sales Per Share
|
0.810 |
|
EBITDA (p.s.)
|
-1.114 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-280 |
|
Levered Free Cash Flow (M)
|
-161 |
Stock Valuations |
|
PE Ratio
|
-9.67 |
|
PEG Ratio
|
|
|
Price to Book value
|
8.00 |
|
Price to Sales
|
15.40 |
|
Price to Cash Flow
|
-11.49 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
